- $1.68bn
- $1.37bn
- $411.33m
Annual balance sheet for Innoviva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 202 | 291 | 194 | 412 | 567 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 111 | 64.1 | 84.1 | 86.4 | 93.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 314 | 444 | 344 | 554 | 728 |
| Net Property, Plant And Equipment | 0.012 | 3.44 | 3.02 | 2.97 | 12.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 926 | 1,231 | 1,244 | 1,301 | 1,635 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.81 | 135 | 38.1 | 236 | 49.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 512 | 666 | 569 | 610 | 462 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 415 | 566 | 675 | 691 | 1,173 |
| Total Liabilities & Shareholders' Equity | 926 | 1,231 | 1,244 | 1,301 | 1,635 |
| Total Common Shares Outstanding |